Clinical Trials
13
Active:12
Completed:1
Trial Phases
2 Phases
Phase 1:4
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Phase 3
1 (20.0%)Study of Paclitaxel in Patients With Ovarian Cancer
Phase 3
Completed
- Conditions
- Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
- Interventions
- Drug: Paclical®
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Oasmia Pharmaceutical AB
- Target Recruit Count
- 789
- Registration Number
- NCT00989131
- Locations
- 🇧🇾
Gomel Regional Clincial Oncology Center, Gomel, Belarus
🇧🇾Minsk City Clinical Oncology Hospital, Minsk, Belarus
🇧🇾Alexandrov National Cancer Center of Belarus, Minsk, Belarus
News
No news found